Analysts Set Integer Holdings Co. (NYSE:ITGR) Target Price at $145.00

Shares of Integer Holdings Co. (NYSE:ITGR - Get Free Report) have been given a consensus recommendation of "Buy" by the nine analysts that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation, seven have given a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $145.00.

A number of equities research analysts have weighed in on ITGR shares. Raymond James boosted their price objective on Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, April 25th. Oppenheimer cut Integer from an "outperform" rating to a "market perform" rating in a research note on Friday, February 21st. Wall Street Zen upgraded Integer from a "sell" rating to a "hold" rating in a research note on Monday, May 19th. Citigroup upgraded Integer from a "hold" rating to a "strong-buy" rating and upped their price target for the stock from $133.00 to $140.00 in a research note on Thursday, May 22nd. Finally, Benchmark cut their price target on Integer from $150.00 to $140.00 and set a "buy" rating for the company in a research note on Friday, April 25th.

Insider Buying and Selling at Integer

In related news, CEO Joseph W. Dziedzic sold 338,975 shares of the firm's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total value of $41,751,550.75. Following the sale, the chief executive officer now owns 47,000 shares of the company's stock, valued at approximately $5,788,990. This trade represents a 87.82% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 2.16% of the stock is owned by insiders.

Hedge Funds Weigh In On Integer

Hedge funds have recently modified their holdings of the company. Capital Research Global Investors grew its holdings in shares of Integer by 16.0% in the 4th quarter. Capital Research Global Investors now owns 1,410,803 shares of the medical equipment provider's stock worth $186,960,000 after acquiring an additional 194,895 shares during the last quarter. Loomis Sayles & Co. L P boosted its position in Integer by 3.8% during the fourth quarter. Loomis Sayles & Co. L P now owns 558,715 shares of the medical equipment provider's stock valued at $74,041,000 after purchasing an additional 20,688 shares during the last quarter. Congress Asset Management Co. lifted its position in shares of Integer by 4.9% in the first quarter. Congress Asset Management Co. now owns 522,656 shares of the medical equipment provider's stock worth $61,679,000 after buying an additional 24,306 shares during the last quarter. Driehaus Capital Management LLC lifted its position in shares of Integer by 5.5% in the fourth quarter. Driehaus Capital Management LLC now owns 451,464 shares of the medical equipment provider's stock worth $59,828,000 after buying an additional 23,706 shares during the last quarter. Finally, Northern Trust Corp lifted its position in shares of Integer by 14.2% in the fourth quarter. Northern Trust Corp now owns 422,380 shares of the medical equipment provider's stock worth $55,974,000 after buying an additional 52,556 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Stock Down 1.8%

ITGR stock traded down $2.14 during trading on Monday, hitting $119.49. 264,207 shares of the company's stock were exchanged, compared to its average volume of 372,590. The company has a current ratio of 2.95, a quick ratio of 2.09 and a debt-to-equity ratio of 0.62. Integer has a 52-week low of $104.93 and a 52-week high of $146.36. The business has a 50-day moving average price of $118.47 and a two-hundred day moving average price of $128.95. The stock has a market capitalization of $4.17 billion, a price-to-earnings ratio of 35.56, a PEG ratio of 1.72 and a beta of 1.03.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. Integer had a return on equity of 11.65% and a net margin of 6.92%. The company had revenue of $437.39 million during the quarter, compared to analysts' expectations of $428.51 million. During the same quarter in the previous year, the business earned $1.14 earnings per share. The firm's revenue for the quarter was up 7.3% on a year-over-year basis. As a group, equities research analysts expect that Integer will post 6.01 EPS for the current year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.